促炎细胞因子
炎症
肾
下调和上调
基因沉默
发病机制
医学
急性肾损伤
巨噬细胞
免疫学
癌症研究
效应器
肾脏疾病
核糖核酸
小干扰RNA
肾病科
肾脏疾病
生物
白细胞介素6
细胞因子
小RNA
RNA干扰
作者
Yu-hang Dong,Shuai-shuai Xie,Shuai Sun,Yu Ren,Qin Yang,Jie Wei,Rui Hou,Xiangyu Li,Jingwen Wu,Wen‐xian Ma,Ju-tao Yu,Mengting He,Chang Li,Jia-nan Wang,Ming-Lu Ji,Zi-yi Liu,Zi-yi Liu,Ze-hui Dong,Xiao-yu Shen,Xin-yu Chen
标识
DOI:10.1073/pnas.2511296123
摘要
Growing evidence indicates that kidney inflammation is a major contributor to the pathogenesis of various renal diseases, including acute kidney injury (AKI). Although RNA modifications have been implicated in regulating kidney inflammation, their precise roles remain largely unknown. Here, we show that kidney inflammation and injury were associated with elevated RNA 5-methylcytosine (m5C) modifications, primarily driven by the NOP2/Sun RNA methyltransferase family member 7 (NSUN7). Both global and kidney-specific deletion of Nsun7 in mice reduced m5C abundance, attenuated inflammatory responses, and decreased macrophage infiltration, underscoring its proinflammatory role in the kidney. Mechanistically, we identified secreted protein acidic and cysteine-rich (SPARC) as a major downstream effector of NSUN7. SPARC upregulation amplified inflammatory responses in renal tubular epithelial cells by interacting with high mobility group box 1 and further promoted proinflammatory macrophage infiltration via tubular-macrophage crosstalk. Notably, therapeutic silencing of Nsun7 using a kidney-specific DNA tetrahedral molecular carrier developed for this study effectively alleviated inflammation and improved renal outcomes in AKI models. Collectively, our findings identify NSUN7 as a key driver of renal inflammation via SPARC regulation and underscore its potential as a therapeutic target in inflammatory kidney diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI